↑Yim JH, Kim YJ, Ko JH, Cho YE, Kim SM, Kim JY, Lee S, Park JH (Oct 2007). "The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death". Cell Death Differ. 14 (11): 1872–9. doi:10.1038/sj.cdd.4402204. PMID17657248.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.
Okahara F, Ikawa H, Kanaho Y, Maehama T (2004). "Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein". J. Biol. Chem. 279 (44): 45300–3. doi:10.1074/jbc.C400377200. PMID15355975.
Yim JH, Kim YJ, Cho YE, et al. (2007). "GLTSCR2 sensitizes cells to hypoxic injury without involvement of mitochondrial apoptotic cascades". Pathobiology. 74 (5): 301–8. doi:10.1159/000105813. PMID17890897.